SANBODY Trademark

Trademark Overview


On Tuesday, March 12, 2024, a trademark application was filed for SANBODY with the United States Patent and Trademark Office. The USPTO has given the SANBODY trademark a serial number of 79399862. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 28, 2025. This trademark is owned by Innovent Biologics (Suzhou) Co., Ltd.. The SANBODY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal disorders; gases for medical purposes; medicines for human purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; drugs for medical purposes for the treatment of fever; dietetic preparations adapted for medical purposes; biological preparations for veterinary purposes for the treatment of infection; biocides; medical dressings; tissues impregnated with antibacterial preparations; dental abrasives; diapers for pet

Scientific research featuring technical project studies in the field of vaccine design; scientific research in the field of pharmaceuticals; research and development of new products for others; scientific laboratory services; technological research in the field of immunotherapy; chemical research; research and development services in the field of chemistry; scientific research in the nature of conducting clinical trials for others; biological research; bacteriological research
sanbody

General Information


Serial Number79399862
Word MarkSANBODY
Filing DateTuesday, March 12, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal disorders; gases for medical purposes; medicines for human purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; drugs for medical purposes for the treatment of fever; dietetic preparations adapted for medical purposes; biological preparations for veterinary purposes for the treatment of infection; biocides; medical dressings; tissues impregnated with antibacterial preparations; dental abrasives; diapers for pet
Pseudo MarkSAN BODY
Goods and ServicesScientific research featuring technical project studies in the field of vaccine design; scientific research in the field of pharmaceuticals; research and development of new products for others; scientific laboratory services; technological research in the field of immunotherapy; chemical research; research and development services in the field of chemistry; scientific research in the nature of conducting clinical trials for others; biological research; bacteriological research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 18, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuzhou City, Jiangsu Province
CN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuzhou City, Jiangsu Province
CN

Trademark Events


Event DateEvent Description
Thursday, July 11, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, July 18, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, July 24, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, July 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 23, 2024ASSIGNED TO EXAMINER
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Friday, September 27, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 2, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 19, 2024REFUSAL PROCESSED BY IB
Sunday, December 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, December 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2024REFUSAL PROCESSED BY MPU
Sunday, December 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, December 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, December 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED